Strand Life Sciences

“Hereditary cancer testing allowed me to understand my condition better, and also alerted my family to who could be at increased risk for cancer.”

Ameeta Srivastava, 59

“I love life too much to give up! Multiple rounds of failed chemotherapy did not make me lose hope. Genetic testing helped identify a new generation drug to keep my cancer in remission.”

Meena Nandal, 56

“If a genetic test had been done when I was first diagnosed with breast cancer, I could have avoided getting cancer again in the other breast.”

Tamannah, 30

“Genetic testing helped my doctor choose a new generation drug to control my lung cancer.”

Dhaval Pandya, 64

“Triple negative breast cancer can be quite an opponent. However, genetic testing empowered my doctor and me to take the right treatment decisions and battle the disease.”

Dimple Bawa, 34

“Multiple cancers in my family prompted me to get a genetic test done. My ovarian cancer was found to be hereditary. This information can now help my daughter to take preventive steps to avoid cancer.”

Suman, 52

“Strand’s test helped eliminate therapies that were not going to work, and identified the right chemo-therapy for controlling my colorectal cancer right from the start.”

Sushant Koparkar, 44

“Genetic testing revealed certain mutations in my genome which could be targeted with precise drugs to eliminate the cancer with minimal side effects.”

Humaira, 57

“My six year fight with cancer would have been shorter had I known about personalized therapy earlier.”

G Padmanabhan, 78

“I took charge after my ovarian cancer diagnosis. Genetic testing revealed hereditary cancer. Four of my family members tested positive for BRCA1. This information was crucial for us to take preventive health measures.”

Sunita Karmarkar, 60

“Identifying the right targeted therapy for my cancer allowed my doctor to choose the best first-line treament!”

Rashmi Eashwar, 68

“As a young cancer patient, the genetic test provided much improved quality of life through targeted treatment despite a diagnosis of aggressive disease.”

Namita, 24

“My son’s condition was undiagnosed for many years. Genetic testing at Strand revealed GSD Type III disease.”

Sagar Kothanur’s Parents

“Our daughter was suffering from seizures and hypoglycemia for close to a decade. Genetic testing at Strand helped us identify the cause, and take appropriate management measures.”

Arpita’s Parents

“Strand’s powerful bioinformatics solutions helped our daughter’s diagnosis, which would not have been possible otherwise.”

Baby Snigdha’s Parents

“My personal encounter with colon cancer, and multiple cancers in the family should have been a warning for hereditary cancer. Timely genetic testing could have helped me detect my cancer earlier.”

Saraswathi Subramanian, 65

“After a prolonged search for answers, genetic testing at Strand revealed rare mutations in the GNE gene, which are the cause of my progressive muscle degeneration.”

Vikram Reddy, 43

“Identifying the right targeted therapy for my cancer has given me a better quality of life despite my cancer diagnosis!”

Amandeep Malhotra, 45

“Knowing the exact mutations that caused my cancer helped my doctor select the right targeted treatment.”

Sunetra Deshmukh, 65

“Knowing that our young son has a cardiac condition was disturbing. Testing at Strand gave us more knowledge, which helped us incorporate lifestyle changes for his well-being.”

Karthik’s Parents

“I was relieved when I understood that monitoring my cancer was possible using Strand Liquid Biopsy.”

Mridula, 63

“My rectal cancer diagnosis at 23 years, coupled with a very strong family history of cancer warranted genetic testing. I, along with other family members were found to be positive for a TP53 mutation, suggestive of Li-Fraumeni syndrome.”

Anmol Thakkar, 23

“Clinical tests showed abnormalities in our just-born daughter. Genetic testing accurately identified the disorder. This information has helped us better manage our baby’s condition.”

Baby Sanaa’s Parents

“Our physician suspected my daughter’s condition to be genetic in origin because of consanguinity in our family. The Strand Clinical Exome Test confirmed his diagnosis.”

Parineeta’s Parents

“My older sister and I were diagnosed with breast cancer. However, we thought it wasn’t hereditary since my mother’s family had no history of cancer. Little did we realize that fathers could also transmit the faulty gene responsible for breast cancer.”

Chandana, 53

“Diagnosis with a rare ovarian cancer type gave me and my doctor limited options for treatment. Having done the genetic test increased my chances of getting the right treatment for my individual cancer. I look forward to a healed and healthy life.”

Samiran Kaur, 53

“My diagnosis of colon cancer and a strong family history prompted me to undergo genetic testing. Further testing of my family helped us understand the presence of Lynch Syndrome in various individuals. Genetic testing has helped us to be prepared and take preventive measures against cancer.”

Samar Mohite, 49

“My family has a strong history of breast and throat cancer. Therefore, I wanted to be sure that I do not have a risk for developing hereditary cancer during my lifetime. Fortunately, my results were negative. I feel empowered to lead a healthy lifestyle and relieved that my cancer risk is low.”

Ruchira, 40

“Genetic testing helped us to accurately diagnose retinoblastoma (RB) in our two-year-old son. RB can be a fatal disease, if not diagnosed early, leading to secondary cancers. Knowing the presence of a genetic mutation has now alerted us to constantly monitor his eyes, and also look out for other unusual symptoms.”

Sujay’s parents

“Being diagnosed with ovarian cancer, and having a family history of cancer got me worried about the cancer being hereditary. Luckily, genetic testing proved that none of our three children have inherited my BRCA1 mutation. This knowledge has put our entire family at ease and established a low risk for hereditary cancer.”

Nayanika Das, 65

“My mother and many relatives were affected with cancer. Early genetic testing could have informed us that the cancer in the family was hereditary. Unfortunately, a few years later, I developed cancer. I would strongly advise individuals with a strong family history to undergo genetic testing so that their risk for cancer can be better managed.”

Sumana Chakraborty, 30

“Liquid Biopsy has made it possible to keep a constant track of my condition for any possible chances of recurrence in the future.”

Preet Jhurani, 65

“Using a combination of genetic tests performed on my tumor and blood samples, I am able to track my bladder cancer.”

Ashfaq Mohammed, 75

“A comprehensive tissue-specific panel comprising NGS, FISH and IHC techniques provided a therapeutic roadmap for personalized treatment of my lung cancer.”

Farrokh Daftari, 59

“Hereditary cancer testing revealed that my cousin and I had mutations in the BRCA1 genes, establishing the hereditary nature of cancer, and also qualifying us to receive PARP inhibitor therapy.”

Urmi Gehlot, 44

“Men being diagnosed with breast cancer is extremely rare. This prompted my physician to perform a genetic test, which revealed a hereditary angle to my cancer. This information has helped me be aware of the risk of occurrence of other cancers in future.”

KV Arumugham, 63

“For my cancer, genetic testing revealed drug options in clinical trials giving me a better chance to fight back.”

Prateek Saini, 35

“With no family history of disorders, the Strand Clinical Exome Test helped diagnose Kabuki Syndrome over the alternative, Noonan Syndrome, if we had looked at symptoms alone.”

Baby Sphoorti’s Parents

“A combination of liquid and solid biopsies provided a better picture of mutations in my tumor and allowed my doctor to advise the most appropriate targeted treatment.”

Tripti Vasudev, 61

“Given that we had lost two of our precious children to muscular dystrophy, we wanted to ensure that the current pregnancy would be safe. The Strand test gave us confidence to go ahead with this pregnancy. We are now blessed with a healthy child!”

Radhika and Sundar

“My diagnosis of Retinitis pigmentosa was confirmed with the Strand genetic test, which also gave me information on the genes causing the disease.”

Swati Koparkar, 33

“Strand Clinical Exome Test provides clarity on the early deaths of a couple’s two children due to inherited Inborn Errors of Metabolism disorder and helps with planning future pregnancies.”

Rohit’s Parents

“The Strand Genetic Test identified that my cancer was hereditary because of a mutation in the BRCA1 gene. This genetic status enabled me to receive PARP inhibitor therapy. Also, the test revealed that my daughter’s risk for hereditary cancer was negative, giving her peace of mind.”

Adira Joseph, 44

“Genetic Testing through Strand’s Clinical Exome Test confirmed that our son had developed Ataxia due to certain gene mutations. In addition, testing revealed that we were also carriers for the same mutations. This information becomes crucial for us when we plan another pregnancy.”

Ardarferoze Vakil’s Parents

“Our child Sireesha had shown signs of developmental delay and poor intake of food from birth. Clinical diagnosis and confirmatory genetic testing revealed a case of Cornelia de Lange Syndrome (CdLS). Genetic testing and counseling has helped us better understand her condition for future treatment.”

Sireesha’s Parents

“I feel in control of my treatment as the genetic test has opened up options to consider liquid biopsy to monitor my disease’s resistance to therapy.”

Aniket Waradkar, 59

“I got a 360 degree view of my cancer profile using the StrandAdvantage 152-gene test, helping me understand my treatment better and be at peace with the probabilities.”

Ila Jindal, 53

“It took us almost 6 years to diagnose our daughter’s frequent epileptic seizures. The Strand Clinical Exome test not only helped identify the condition but also helped identify accurate treatment options.”

Sonalika’s Parents

“Genetic testing revealed that my colorectal cancer was caused by a hereditary mutation. Testing in other family members revealed that two of them were positive for the same mutation, and five were negative. This information has helped us understand our cancer risk and adopt pre-emptive care to reduce our personal risk for cancer.”

Sohanlal Shah, 52

“Our daughter Anagha started developing seizures within a few days of birth. In search for answers to the problem, the Strand Clinical Exome Test helped us identify the condition as Early-infantile epileptic encephalopathy 4 (EIEE4), which is caused by a genetic mutation of the STXBP1 gene.”

Anagha’s Parents

“Our son was diagnosed with nephrotic syndrome when he was less than one year old and put on many medications to manage the condition. However, two year on, the Strand Clinical Exome test helped diagnose congenital nephrotic syndrome due to a mutation in the NPSH1 gene, which prompted the doctor to take Tanmay off immunosuppressants.”

Tanmay’s Parents

“The doctor prescribed the Strand Clinical Exome test for Debasis with the intention of arriving at a differential diagnosis between known leukodystrophy disorders. Instead, a mutation was found in the RPIA gene in his genome. As a result, Debasis was diagnosed with the rare enzymopathy ribose-5-phosphate isomerase deficiency, which provided a clearer picture as to the origin of our son’s cognitive disabilities and prognosis of the condition.”

Debasis’ Parents